Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 13  •  04:00PM ET
4.10
Dollar change
+0.34
Percentage change
9.04
%
Today, 8:20 AMNephros announces entry into the Puerto Rico market, targeting a roughly $10 million water filtration opportunity across medical and commercial sectors.
Index- P/E29.69 EPS (ttm)0.14 Insider Own11.31% Shs Outstand10.63M Perf Week5.94%
Market Cap43.57M Forward P/E27.33 EPS next Y0.15 Insider Trans0.00% Shs Float9.43M Perf Month-7.03%
Enterprise Value39.55M PEG0.16 EPS next Q0.01 Inst Own48.22% Short Float0.10% Perf Quarter-10.09%
Income1.48M P/S2.43 EPS this Y1000.00% Inst Trans0.35% Short Ratio0.18 Perf Half Y2.50%
Sales17.93M P/B4.35 EPS next Y36.36% ROA12.53% Short Interest0.01M Perf YTD-15.98%
Book/sh0.94 P/C8.43 EPS next 5Y175.89% ROE16.29% 52W High6.42 -36.14% Perf Year162.82%
Cash/sh0.49 P/FCF16.02 EPS past 3/5Y- - ROIC13.74% 52W Low1.39 194.96% Perf 3Y253.45%
Dividend Est.- EV/EBITDA24.88 Sales past 3/5Y11.50% 6.51% Gross Margin62.45% Volatility9.01% 8.13% Perf 5Y-54.09%
Dividend TTM- EV/Sales2.21 EPS Y/Y TTM258.44% Oper. Margin8.06% ATR (14)0.34 Perf 10Y62.73%
Dividend Ex-Date- Quick Ratio3.23 Sales Y/Y TTM32.36% Profit Margin8.26% RSI (14)45.11 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio4.34 EPS Q/Q75.29% SMA20-4.60% Beta1.43 Target Price7.00
Payout0.00% Debt/Eq0.11 Sales Q/Q35.42% SMA50-12.70% Rel Volume0.20 Prev Close3.76
Employees31 LT Debt/Eq0.08 EarningsNov 06 AMC SMA200-2.12% Avg Volume55.56K Price4.10
IPOSep 21, 2004 Option/ShortNo / Yes EPS/Sales Surpr.250.00% 23.21% Trades Volume11,146 Change9.04%
Date Action Analyst Rating Change Price Target Change
Jan-26-21Initiated B. Riley Securities Buy $12.50
Today 08:16AM
Dec-11-25 09:00AM
Nov-10-25 08:04PM
Nov-06-25 04:10PM
Oct-30-25 04:00PM
09:00AM Loading…
Oct-08-25 09:00AM
Oct-07-25 10:41AM
Aug-08-25 11:00PM
Aug-07-25 04:00PM
Jul-31-25 04:00PM
Jul-15-25 09:19AM
May-28-25 09:00AM
May-08-25 04:00PM
May-07-25 11:46AM
Apr-30-25 04:00PM
09:00AM Loading…
Apr-28-25 09:00AM
Mar-06-25 04:00PM
Mar-05-25 07:36AM
Feb-26-25 04:00PM
Dec-04-24 09:00AM
Nov-08-24 04:03PM
Nov-07-24 04:01PM
Nov-06-24 07:56AM
Oct-31-24 07:30AM
Oct-25-24 09:10AM
Oct-24-24 09:00AM
Oct-17-24 09:00AM
Oct-09-24 05:56PM
Aug-08-24 04:01PM
Aug-01-24 07:30AM
04:15PM Loading…
May-09-24 04:15PM
May-02-24 07:30AM
Apr-29-24 09:00AM
Apr-23-24 07:30AM
Mar-08-24 01:01PM
Mar-07-24 04:15PM
Feb-29-24 04:30PM
Nov-11-23 12:41PM
Nov-08-23 04:15PM
Nov-01-23 07:30AM
Oct-25-23 07:30AM
Sep-19-23 04:30PM
Aug-09-23 04:15PM
Jul-26-23 07:30AM
May-24-23 07:30AM
May-10-23 04:15PM
May-08-23 07:30AM
Apr-26-23 07:30AM
Apr-04-23 07:30AM
Mar-08-23 04:15PM
Mar-01-23 04:30PM
Feb-22-23 04:30PM
Jan-11-23 07:30AM
Nov-02-22 04:15PM
Oct-19-22 07:30AM
Oct-12-22 07:30AM
Oct-11-22 07:30AM
Sep-28-22 07:30AM
Sep-08-22 04:00PM
Aug-13-22 08:22AM
Aug-10-22 04:15PM
Jul-27-22 07:30AM
Jul-06-22 07:30AM
May-17-22 07:30AM
May-04-22 04:15PM
Apr-27-22 07:30AM
Apr-26-22 07:30AM
Mar-21-22 07:30AM
Feb-28-22 07:30AM
Feb-23-22 04:15PM
Feb-09-22 07:30AM
Jan-13-22 07:30AM
Jan-11-22 07:30AM
Nov-23-21 04:15PM
Nov-08-21 07:30AM
Nov-04-21 04:15PM
Oct-21-21 07:30AM
Oct-08-21 07:30AM
Oct-05-21 07:30AM
Sep-15-21 09:39AM
Sep-06-21 11:42AM
Sep-01-21 07:30AM
Aug-05-21 04:15PM
Jul-28-21 03:03PM
Jul-12-21 07:30AM
Jul-09-21 04:18PM
Jul-08-21 11:20AM
07:30AM
05:07AM
Jun-29-21 08:50AM
Jun-23-21 09:35AM
May-31-21 08:50AM
May-06-21 04:15PM
02:45PM
Apr-26-21 07:30AM
Apr-09-21 05:29AM
Apr-05-21 07:30AM
Mar-16-21 07:45AM
Mar-10-21 07:30AM
Mar-04-21 02:07AM
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment consists of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate, and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.
Last Close
Feb 13  •  04:00PM ET
2.30
Dollar change
+0.08
Percentage change
3.60
%
TUSK Mammoth Energy Services Inc daily Stock Chart
IndexRUT P/E- EPS (ttm)-1.63 Insider Own2.66% Shs Outstand48.19M Perf Week-1.29%
Market Cap110.85M Forward P/E- EPS next Y- Insider Trans0.79% Shs Float46.91M Perf Month0.00%
Enterprise Value-24.73M PEG- EPS next Q- Inst Own74.57% Short Float1.50% Perf Quarter15.58%
Income-78.55M P/S0.75 EPS this Y- Inst Trans-0.57% Short Ratio2.64 Perf Half Y0.44%
Sales146.88M P/B0.44 EPS next Y- ROA-16.35% Short Interest0.70M Perf YTD24.32%
Book/sh5.17 P/C0.79 EPS next 5Y- ROE-24.62% 52W High3.12 -26.16% Perf Year-22.30%
Cash/sh2.91 P/FCF1.36 EPS past 3/5Y-25.45% -19.69% ROIC-31.25% 52W Low1.68 36.90% Perf 3Y-64.62%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-6.37% -21.36% Gross Margin-0.26% Volatility7.57% 6.38% Perf 5Y-47.85%
Dividend TTM- EV/Sales-0.17 EPS Y/Y TTM60.44% Oper. Margin-18.58% ATR (14)0.15 Perf 10Y-
Dividend Ex-DateMay 09, 2019 Quick Ratio2.43 Sales Y/Y TTM-21.67% Profit Margin-53.48% RSI (14)52.14 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio2.48 EPS Q/Q47.78% SMA20-1.35% Beta0.96 Target Price4.20
Payout- Debt/Eq0.02 Sales Q/Q-63.01% SMA508.98% Rel Volume0.30 Prev Close2.22
Employees639 LT Debt/Eq0.01 EarningsMar 06 BMO SMA200-1.25% Avg Volume267.03K Price2.30
IPOOct 14, 2016 Option/ShortYes / Yes EPS/Sales Surpr.- - Trades Volume80,251 Change3.60%
Date Action Analyst Rating Change Price Target Change
Sep-30-19Downgrade Barclays Overweight → Equal Weight $6.50 → $3.50
Sep-11-19Downgrade Johnson Rice Buy → Hold
Aug-05-19Reiterated Imperial Capital Outperform $18 → $10
Jun-07-19Downgrade Stephens Overweight → Equal-Weight $25 → $7
May-03-19Reiterated Imperial Capital Outperform $22 → $18
Mar-19-19Downgrade Credit Suisse Outperform → Neutral $33 → $17
Mar-18-19Reiterated Imperial Capital Outperform $30 → $24
Mar-18-19Downgrade Tudor Pickering Buy → Hold
Jan-09-19Reiterated Imperial Capital Outperform $40 → $30
Jan-04-19Upgrade Tudor Pickering Hold → Buy
Feb-05-26 04:30PM
Dec-02-25 04:30PM
Oct-31-25 05:05PM
08:00AM
Oct-30-25 09:37AM
04:30PM Loading…
Oct-16-25 04:30PM
Aug-08-25 08:00AM
Jul-28-25 04:15PM
Jun-06-25 04:04PM
May-08-25 03:24AM
May-07-25 04:02PM
04:02PM
08:00AM
Apr-28-25 04:15PM
Apr-14-25 07:00AM
02:04AM Loading…
Mar-08-25 02:04AM
12:58AM
Mar-07-25 08:00AM
Mar-06-25 07:10AM
Feb-25-25 04:15PM
Dec-17-24 04:58PM
Nov-07-24 07:00AM
Nov-02-24 03:04AM
01:34AM
Nov-01-24 07:00AM
Oct-31-24 09:06AM
Oct-29-24 03:40PM
Oct-28-24 08:00AM
Oct-21-24 07:00AM
Oct-03-24 07:00AM
04:15PM Loading…
Oct-01-24 04:15PM
Sep-19-24 07:00AM
Aug-09-24 07:00AM
Jul-29-24 08:00AM
Jul-22-24 04:15PM
May-06-24 09:52AM
May-03-24 12:21AM
May-02-24 12:56PM
10:12AM
07:00AM
Apr-22-24 04:15PM
Mar-04-24 09:17AM
Mar-01-24 11:31PM
09:32AM
07:00AM
Feb-12-24 04:15PM
Dec-06-23 08:00AM
Nov-11-23 11:29AM
Nov-09-23 11:08PM
09:53AM
07:00AM
Nov-01-23 08:00AM
Oct-19-23 08:00AM
Aug-11-23 11:52PM
08:00AM
Jul-20-23 04:15PM
Jul-07-23 10:21AM
Jun-16-23 03:23PM
Jun-15-23 08:00AM
Jun-07-23 07:13AM
May-27-23 08:57AM
May-04-23 08:17AM
Apr-27-23 04:01PM
Apr-21-23 06:35AM
Apr-19-23 08:30AM
Feb-27-23 10:46PM
Feb-26-23 07:27AM
Feb-24-23 06:52AM
Feb-23-23 04:01PM
Feb-06-23 04:15PM
Jan-28-23 08:49AM
Jan-24-23 04:15PM
Jan-19-23 05:07PM
Jan-17-23 04:15PM
Dec-06-22 04:15PM
Nov-01-22 04:15PM
Oct-31-22 10:25AM
Oct-27-22 04:01PM
Oct-17-22 04:15PM
Sep-26-22 04:15PM
Aug-24-22 04:15PM
Aug-21-22 09:15AM
Jul-28-22 11:00PM
04:01PM
Jul-14-22 04:36PM
Jun-14-22 04:15PM
Jun-07-22 07:00AM
May-24-22 06:33AM
May-10-22 03:00PM
May-09-22 04:15PM
Apr-26-22 04:15PM
Mar-31-22 08:30AM
Mar-29-22 08:00AM
Mar-14-22 08:30AM
07:33AM
Mar-04-22 02:00PM
08:30AM
06:00AM
Feb-25-22 04:15PM
Dec-01-21 08:00AM
Mammoth Energy Services, Inc. engages in the exploration and development of North American onshore unconventional oil and natural gas reserves. It operates through the following segments: Well Completion, Infrastructure, Sand, Drilling, and All Other. The Well Completion segment focuses on hydraulic fracturing and water transfer services primarily in the Utica Shale of Eastern Ohio, Marcellus Shale in Pennsylvania, and the mid-continent region. The Infrastructure segment offers electric utility infrastructure services to government-funded utilities, private utilities, public investor-owned utilities and co-operative utilities in the northeastern, southwestern, midwestern, and western portions of the United States. The Sand segment is involved in mining, processing, and sale of sand for use in hydraulic fracturing. The Drilling segment includes contract land and directional drilling services primarily in the Permian Basin and mid-continent region. The company was founded on June 3, 2016 and is headquartered in Oklahoma City, OK.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Amron Arthur HDirectorDec 11 '25Buy1.8910,00018,90057,135Dec 15 05:04 PM
SMITH ARTHUR LDirectorAug 12 '25Proposed Sale2.26102,178231,000Aug 12 10:22 AM
SMITH ARTHUR LDirectorMay 22 '25Sale2.5120,00050,200130,034May 27 05:29 PM
SMITH ARTHUR LDirectorMay 20 '25Sale2.5150,000125,500150,034May 21 05:35 PM
SMITH ARTHUR LDirectorMay 19 '25Sale2.4915,00037,350200,034May 21 05:35 PM
SMITH ARTHUR LDirectorMay 12 '25Proposed Sale2.53100,000253,000May 12 01:59 PM